Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.
Hyperfine, Inc.
HYPRNASDAQ
Wall Street Score · overall investment25/100
$0.78USD+$0.03 (+4.66%)
Severe listing-compliance risk
The share price is below $1 and the stored reverse-split/listing-risk level is HIGH. No verified reverse-split authorization or announced reverse split is currently recorded. This is a risk signal, not confirmation that Nasdaq has issued a deficiency notice.
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system.
How they make money
Hyperfine generates revenue primarily through the sale of its Swoop portable MRI systems and associated service contracts. The company also derives income from the licensing and sale of its proprietary Optive AI software, which enhances image quality and scanner usability for healthcare providers in hospital and neurology office settings.
Products & services
The Swoop system is an FDA-cleared, AI-powered portable magnetic resonance imaging (MRI) device designed for brain imaging. It is complemented by Optive AI software, which improves image resolution and uniformity.
Brands & revenue mix
Swoop
The company's primary portable MRI brain imaging system.
Separate brand revenue is not available in this research.Source
Optive AI
Software suite designed to enhance image resolution and scanner usability.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Calculated from reported segment revenue. Check the source period and revenue basis before comparing shares. Categories can overlap and may not add to 100%.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
As of the period ended September 30, 2025, the company reported that one customer accounted for 10% or more of total net revenue for the nine-month period.
Suppliers, materials & equipment
Contract Manufacturers — The company relies on third-party contract manufacturers for the production of its Swoop system components; the specific supplier names are unnamed.Source
Competitors
General Electric Company — Competes in the broader medical imaging and MRI market.Source
Siemens Healthineers AG — Competes in the broader medical imaging and MRI market.Source
Koninklijke Philips N.V. — Competes in the broader medical imaging and MRI market.Source
These are saved observations about business performance, not predictions. Review the company filings alongside the interpretation below. Latest stored financial period end: 2026-06-30.
Diluted weighted-average shares increased 27.8% year over year.
Compare per-share results with total earnings and inspect the equity footnote. A change in weighted-average shares does not by itself establish the cause, the number of shares issued today, or the economic effect of a split.
Total debt increased 5535.7% versus the same quarter last year.
Compare the added borrowing with available cash, cash generation and maturities. A percentage increase from a small starting balance can look large without measuring the full debt burden.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
25
Poor
PoorElite
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
36
Poor
Financial Strength
27
Business Quality / Moat
33
Management
40
Growth Quality
61
Risk / Durability
26
Weak Company · Expensive Stock
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
34
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
47/100
Building Historical Record
Model Score 47/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
Reverse-split / listing-compliance risk: HIGH
This is a risk signal, not a prediction. It is separate from Wall Street Score and does not change the company score. It looks for listing-pressure signals such as prolonged Nasdaq trading below $1, very low share price, micro-cap size, negative free cash flow, and verified recent reverse splits.
Risk indicator: 55/100
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
What we like
No strong positive signal is being highlighted from the currently available summary data.
What to watch
•Valuation is a weaker part of the current profile
•Revenue fundamentals are weak
•Debt / balance-sheet profile needs attention
•Asset quality is a weaker factor
Company-specific research
Questions worth answering for HYPR
Research inputs 100% complete
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
•Can HYPR maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
•How long can HYPR fund negative free cash flow using its current cash position before it may need more debt or new shares?
•How is HYPR likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
•What specifically needs to improve for HYPR to reach sustainable profitability?
•What future growth or profitability would be needed to justify HYPR's current valuation?
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
Volatility = How violently is it moving?
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Community Sentiment
0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)
No personal call yet on HYPR.
Potential upside factors
+Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
−Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Devices industry.
−Dependence on third-party manufacturers.
−Regulatory approval and compliance requirements.
−Diluted weighted-average shares increased 27.8% year over year.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdown
Wall Street Score
Very Weak25/ 100
Weak (0–50)Fair (51–71)Strong (72+)
Debt
Poor
34
Debt Cost—
Debt Reduction YoY-16.7%
Debt / Equity0.01x
Tap for breakdown →
Revenue
Poor
28
Revenue YoY21.9%
Revenue CAGR10.9%
Net Margin-210.8%
Tap for breakdown →
Asset
Poor
38
Asset Growth YoY-6.2%
Liquidation/Share$0.39
Net Assets/MCap0.73x
Tap for breakdown →
Capital
Poor
0
Earnings Yield-51.2%
Buyback Yield0.0%
Debt Cost—
Tap for breakdown →
Management
Weak
40
ROIC-552.4%
ROE-94.8%
ROA-55.3%
Tap for breakdown →
Moat
Poor
33
EPS Growth—
FCF/Share Growth—
Rev/Share Growth20.1%
Tap for breakdown →
Valuation
Poor
0
Intrinsic Value—
Value Reference—
MOS—
Tap for breakdown →
Buffett
Poor
31
Revenue28
Moat33
Valuation0
Tap for breakdown →
MOS
Poor
0
MOS %—
Value Reference—
Deep Discount Reference—
Tap for breakdown →
Financial
Poor
32
Interest Coverage—
ROIC-552.4%
FCF Yield-42.8%
Tap for breakdown →
Master
Poor
26
Financial32
Valuation0
Debt34
Tap for breakdown →
Resilience
Fair
60
Survival Years1.2 yrs
Current Ratio4.34x
FCF Margin-214.8%
Tap for breakdown →
Was this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
YesNot yetDismiss
Score Changes
3 historical score records available
Previous Score
25
Aug 14, 2026
Change
+0.3
points
Current Score
25
Oct 1, 2026
Category Changes
Revenue+0.2
Debt0
Assets+2.2
Capital0
Management0
Moat0
Valuation0
Buffett+0.3
HYPR increased 0.3 points because Asset improved by 2.2 points.
Positive Contributors
+ Asset improved by 2.2 points
Projected Score
Projected Score
26
Projected Change
+0.8 points
Preliminary comparable-period financial changes suggest improvement of approximately 0.8 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Valuation unavailable
Current Price
$0.78
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Value Reference: —
Deep Discount Reference: —
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Monetary values in USD. Share counts in raw units.
Income StatementBalance SheetCash Flow
AnnualQuarterlyTTM + Annual
All rows
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
Line Item
TTM
2025
2024
2023
2022
2021
2020
2019
Revenue
$16.5M
$13.6M
$12.9M
$11.0M
····
····
····
····
Cost of Revenue
$8.0M
$6.8M
$7.0M
$6.3M
····
····
····
····
Gross Profit
$8.5M
$6.8M
$5.9M
$4.8M
····
····
····
····
Research & Development
$15.6M
$17.5M
$22.5M
$22.5M
····
····
····
····
SG&A Expenses
$26.5M
$26.4M
$26.6M
$30.4M
····
····
····
····
Operating Expenses
$42.1M
$43.8M
$49.1M
$52.9M
····
····
····
····
EBITDA
-$32.4M
-$33.4M
-$39.7M
-$43.2M
····
····
····
····
Operating Income
-$33.6M
-$37.1M
-$43.2M
-$48.1M
····
····
····
····
Interest Expense
$616K
$0.00
$0.00
$0.00
····
····
····
····
Income Before Tax
-$34.9M
-$35.6M
-$40.7M
-$44.2M
····
····
····
····
Income Tax Expense
$0.00
$0.00
$0.00
$0.00
····
····
····
····
Net Income
-$34.9M
-$35.6M
-$40.7M
-$44.2M
····
····
····
····
Basic EPS
$-0.38
$-0.43
$-0.56
$-0.62
····
····
····
····
Basic Shares
99.80M
94.20M
72.41M
71.32M
····
····
····
····
Diluted Shares
99.80M
94.20M
72.41M
71.32M
····
····
····
····
Upgrade to Premium for up to 10 annual periods, where available.
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
Margins expanded
Cash position grew
What Weakened
Debt increased
Potential Score Impact
Positive indicators included revenue growth, cash levels, net income margin. Pressure indicators included EPS growth, debt levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 44.8%. EPS declined 25.0%. Cash increased 71.0%. Total debt increased 5535.7%. Net income margin improved by 104.0 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Upgrade to Premium to unlock all earnings history.View plans
Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.
Dividend HistoryShare
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Predictions & Historical PerformanceShare
Conservative Projected Values
3 Years
$———.——
Premium
5 Years
$———.——
Premium
10 Years
$———.——
Premium
Conservative Projection Rate
——%
Premium
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.